Global Active Pharmaceutical Ingredients (API) Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-52580 | Geographical Scope: Global | Publisher: HNY Research
The global Active Pharmaceutical Ingredients (API) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Teva Pfizer Aurobindo Pharma Mylan BASF DSM Hisun Pharmaceutical Novartis Aspen Huahai Pharmaceutical Bayer Shandong Xinhua Pharmaceutical Sun Pharmaceutical Industries Harbin Pharmaceutical NCPC Zhejiang NHU Zhejiang Medicine Northeast Pharm AbbVie Dr. Reddy’s Laboratories LKPC By Types: Synthetic APIs Biotech APIs By Applications: CNS Cardiovascular Genitourinary/Hormonal Drugs Respiratory Rheumatology Diabetes Oncology Others Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Active Pharmaceutical Ingredients (API) Revenue 1.5 Market Analysis by Type 1.5.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Synthetic APIs 1.5.3 Biotech APIs 1.6 Market by Application 1.6.1 Global Active Pharmaceutical Ingredients (API) Market Share by Application: 2022-2027 1.6.2 CNS 1.6.3 Cardiovascular 1.6.4 Genitourinary/Hormonal Drugs 1.6.5 Respiratory 1.6.6 Rheumatology 1.6.7 Diabetes 1.6.8 Oncology 1.6.9 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Active Pharmaceutical Ingredients (API) Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Active Pharmaceutical Ingredients (API) Market Players Profiles 3.1 Teva 3.1.1 Teva Company Profile 3.1.2 Teva Active Pharmaceutical Ingredients (API) Product Specification 3.1.3 Teva Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Pfizer 3.2.1 Pfizer Company Profile 3.2.2 Pfizer Active Pharmaceutical Ingredients (API) Product Specification 3.2.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 Aurobindo Pharma 3.3.1 Aurobindo Pharma Company Profile 3.3.2 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Specification 3.3.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Mylan 3.4.1 Mylan Company Profile 3.4.2 Mylan Active Pharmaceutical Ingredients (API) Product Specification 3.4.3 Mylan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 BASF 3.5.1 BASF Company Profile 3.5.2 BASF Active Pharmaceutical Ingredients (API) Product Specification 3.5.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 DSM 3.6.1 DSM Company Profile 3.6.2 DSM Active Pharmaceutical Ingredients (API) Product Specification 3.6.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Hisun Pharmaceutical 3.7.1 Hisun Pharmaceutical Company Profile 3.7.2 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification 3.7.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Novartis 3.8.1 Novartis Company Profile 3.8.2 Novartis Active Pharmaceutical Ingredients (API) Product Specification 3.8.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Aspen 3.9.1 Aspen Company Profile 3.9.2 Aspen Active Pharmaceutical Ingredients (API) Product Specification 3.9.3 Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Huahai Pharmaceutical 3.10.1 Huahai Pharmaceutical Company Profile 3.10.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification 3.10.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 Bayer 3.11.1 Bayer Company Profile 3.11.2 Bayer Active Pharmaceutical Ingredients (API) Product Specification 3.11.3 Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Shandong Xinhua Pharmaceutical 3.12.1 Shandong Xinhua Pharmaceutical Company Profile 3.12.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification 3.12.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.13 Sun Pharmaceutical Industries 3.13.1 Sun Pharmaceutical Industries Company Profile 3.13.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Specification 3.13.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.14 Harbin Pharmaceutical 3.14.1 Harbin Pharmaceutical Company Profile 3.14.2 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Specification 3.14.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.15 NCPC 3.15.1 NCPC Company Profile 3.15.2 NCPC Active Pharmaceutical Ingredients (API) Product Specification 3.15.3 NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.16 Zhejiang NHU 3.16.1 Zhejiang NHU Company Profile 3.16.2 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Specification 3.16.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.17 Zhejiang Medicine 3.17.1 Zhejiang Medicine Company Profile 3.17.2 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Specification 3.17.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.18 Northeast Pharm 3.18.1 Northeast Pharm Company Profile 3.18.2 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Specification 3.18.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.19 AbbVie 3.19.1 AbbVie Company Profile 3.19.2 AbbVie Active Pharmaceutical Ingredients (API) Product Specification 3.19.3 AbbVie Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.20 Dr. Reddy’s Laboratories 3.20.1 Dr. Reddy’s Laboratories Company Profile 3.20.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Specification 3.20.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.21 LKPC 3.21.1 LKPC Company Profile 3.21.2 LKPC Active Pharmaceutical Ingredients (API) Product Specification 3.21.3 LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Active Pharmaceutical Ingredients (API) Market Competition by Market Players 4.1 Global Active Pharmaceutical Ingredients (API) Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Market Players (2016-2021) 4.3 Global Active Pharmaceutical Ingredients (API) Average Price by Market Players (2016-2021) 5 Global Active Pharmaceutical Ingredients (API) Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.1.2 Active Pharmaceutical Ingredients (API) Key Players in North America (2016-2021) 5.1.3 North America Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.1.4 North America Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.2.2 Active Pharmaceutical Ingredients (API) Key Players in East Asia (2016-2021) 5.2.3 East Asia Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.2.4 East Asia Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.3.2 Active Pharmaceutical Ingredients (API) Key Players in Europe (2016-2021) 5.3.3 Europe Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.3.4 Europe Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.4.2 Active Pharmaceutical Ingredients (API) Key Players in South Asia (2016-2021) 5.4.3 South Asia Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.4.4 South Asia Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.5.2 Active Pharmaceutical Ingredients (API) Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.5.4 Southeast Asia Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.6.2 Active Pharmaceutical Ingredients (API) Key Players in Middle East (2016-2021) 5.6.3 Middle East Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.6.4 Middle East Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.7.2 Active Pharmaceutical Ingredients (API) Key Players in Africa (2016-2021) 5.7.3 Africa Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.7.4 Africa Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.8.2 Active Pharmaceutical Ingredients (API) Key Players in Oceania (2016-2021) 5.8.3 Oceania Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.8.4 Oceania Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.9.2 Active Pharmaceutical Ingredients (API) Key Players in South America (2016-2021) 5.9.3 South America Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.9.4 South America Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Active Pharmaceutical Ingredients (API) Market Size (2016-2021) 5.10.2 Active Pharmaceutical Ingredients (API) Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Active Pharmaceutical Ingredients (API) Market Size by Type (2016-2021) 5.10.4 Rest of the World Active Pharmaceutical Ingredients (API) Market Size by Application (2016-2021) 6 Global Active Pharmaceutical Ingredients (API) Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Active Pharmaceutical Ingredients (API) Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Active Pharmaceutical Ingredients (API) Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Active Pharmaceutical Ingredients (API) Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Active Pharmaceutical Ingredients (API) Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Active Pharmaceutical Ingredients (API) Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Active Pharmaceutical Ingredients (API) Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Active Pharmaceutical Ingredients (API) Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Active Pharmaceutical Ingredients (API) Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Active Pharmaceutical Ingredients (API) Consumption by Countries 7 Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) (2022-2027) 7.2 Global Forecasted Revenue of Active Pharmaceutical Ingredients (API) (2022-2027) 7.3 Global Forecasted Price of Active Pharmaceutical Ingredients (API) (2022-2027) 7.4 Global Forecasted Production of Active Pharmaceutical Ingredients (API) by Region (2022-2027) 7.4.1 North America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.4.3 Europe Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.4.7 Africa Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.4.9 South America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Application (2022-2027) 8 Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country 8.2 East Asia Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country 8.3 Europe Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Countriy 8.4 South Asia Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country 8.5 Southeast Asia Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country 8.6 Middle East Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country 8.7 Africa Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country 8.8 Oceania Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country 8.9 South America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country 8.10 Rest of the world Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country 9 Global Active Pharmaceutical Ingredients (API) Sales by Type (2016-2027) 9.1 Global Active Pharmaceutical Ingredients (API) Historic Market Size by Type (2016-2021) 9.2 Global Active Pharmaceutical Ingredients (API) Forecasted Market Size by Type (2022-2027) 10 Global Active Pharmaceutical Ingredients (API) Consumption by Application (2016-2027) 10.1 Global Active Pharmaceutical Ingredients (API) Historic Market Size by Application (2016-2021) 10.2 Global Active Pharmaceutical Ingredients (API) Forecasted Market Size by Application (2022-2027) 11 Global Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis 11.1 Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API) 12 Global Active Pharmaceutical Ingredients (API) Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Active Pharmaceutical Ingredients (API) Distributors List 12.3 Active Pharmaceutical Ingredients (API) Customers 12.4 Active Pharmaceutical Ingredients (API) Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer